Antonio Bertolotto graduated in medicine and specialized in neurology at the University of Turin. He worked as Clinical Neurologist at the University of Turin from 1981 to1992, and then he moved to the new Centre of the University of Turin at Azienda Ospedaliero-Universitaria S. Luigi, Orbassano (Turin), where he created the MS Clinic that includes the Clinical Neurobiology Laboratory and the Experimental Neurophysiology Laboratory. The MS Clinic at Orbassano since 2002 has become the Regional Referral MS Centre in Piedmont (CRESM). He is involved in clinical activity, research, and education in MS. His daily activity includes diagnosis, treatment of MS patients, and organization of CRESM activities that involved 25 health specialists (neurologists, nurses, biologists, biotechnologists, psychologists, staff personnel). CRESM in March 2012 has in charge more than 1700 MS patients. The Clinical Neurobiology Laboratory serves as the Italy center for the detection of antibodies neutralizing Interferon beta and Natalizumab. The research activity is focused on the detection of nonresponders to DMT, evaluating the effects of pregnancy on gene expression, anti-Aquaporin 4 antibodies, CSF proteomics, haematopoietic stem cell transplantation, and several clinical trials. He has over 115 papers to his credit in peer-reviewed medical journals and in the majority of them Bertolotto is the first or last author. He serves as the Chair of the Regional Neurological MS Commission of the Regional Health Service, and he serves as a Member of the Scientific Board of the Italian Association for MS, of the Therapeutics and Technology Assessment subcommittee of the American Academy of Neurology for Interferon beta Neutralizing antibodies.
Biography Updated on 18 April 2012